Schedule of outstanding warrants (Details) - $ / shares |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Dec. 31, 2025 |
Sep. 30, 2025 |
Sep. 30, 2024 |
|
| Equity [Abstract] | |||
| Warrants outstanding, beginning balance | 24,413,104 | 232,438 | |
| Weighted average price outstanding, beginning balance | $ 2.42 | $ 2.37 | |
| Warrants, issued | 85,413,476 | 24,094,759 | 232,438 |
| Weighted average price, issued | $ 0.39 | $ 0.79 | $ 2.37 |
| Warrants, exercised | (2,756,697) | (50,000) | |
| Weighted average price, exercised | $ 3.00 | ||
| Warrants, expired | (18,437,511) | (232,438) | |
| Weighted average price, expired | $ 0.34 | $ 2.02 | |
| Warrants outstanding, ending balance | 88,632,372 | 24,413,104 | 232,438 |
| Weighted average price outstanding, ending balance | $ 0.91 | $ 2.42 | $ 2.37 |
| Warrants, assumed in merger | 368,345 | ||
| Weighted average price, assumed in merger | $ 109.50 | ||
| X | ||||||||||
- Definition Weighted average exercise price, warrants assumed in merger. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, warrants forfeiture/expired. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, warrants outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, warrants exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, warrants issued. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Other increase (decrease) in number of shares reserved for issuance under non-option equity instrument agreements that is not separately disclosed. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|